These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 6397768)

  • 1. Factor X.
    Jackson CM
    Prog Hemost Thromb; 1984; 7():55-109. PubMed ID: 6397768
    [No Abstract]   [Full Text] [Related]  

  • 2. Protein C.
    Esmon CT
    Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane-bound enzyme complexes in blood coagulation.
    Mann KG
    Prog Hemost Thromb; 1984; 7():1-23. PubMed ID: 6099581
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular mechanisms in blood coagulation.
    Davie EW; Kirby EP
    Curr Top Cell Regul; 1973; 7():51-86. PubMed ID: 4592483
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Activation of coagulation in phospholipid phase].
    Suzuki K
    Rinsho Byori; 1985 Sep; 33(9):966-73. PubMed ID: 3878417
    [No Abstract]   [Full Text] [Related]  

  • 6. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
    Krishnaswamy S; Walker RK
    Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of thrombin-catalyzed reactions in blood coagulation and platelet activation by heparin fractions in the absence of antithrombin III.
    Baruch D; Lindhout T; Wagenvoord R; Hemker HC
    Haemostasis; 1986; 16(2):71-81. PubMed ID: 3086193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood coagulation.
    Jackson CM; Nemerson Y
    Annu Rev Biochem; 1980; 49():765-811. PubMed ID: 6996572
    [No Abstract]   [Full Text] [Related]  

  • 9. Interactions of vitamin K-dependent proteins with calcium ions and phospholipid membranes.
    Nelsestuen GL
    Fed Proc; 1978 Oct; 37(12):2621-5. PubMed ID: 700172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of inhibition of platelet coagulant activity.
    Ellis V; Scully MF; Kakkar VV
    Adv Exp Med Biol; 1985; 192():373-87. PubMed ID: 2422887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characteristics of anticoagulation by covalently immobilized heparin.
    Miura Y; Aoyagi S; Kusada Y; Miyamoto K
    J Biomed Mater Res; 1980 Sep; 14(5):619-30. PubMed ID: 7349668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
    Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
    Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interactions of blood coagulation factors (author's transl)].
    Cierniewski CS; Krajewski T
    Postepy Biochem; 1981; 27(1):81-105. PubMed ID: 6792614
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombin generation and inactivation in the presence of antithrombin III and heparin.
    Lindhout T; Baruch D; Schoen P; Franssen J; Hemker HC
    Biochemistry; 1986 Oct; 25(20):5962-9. PubMed ID: 3790498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of accessory components in the activation of vitamin K-dependent coagulation factors.
    van Rijn JL; Zwaal RF; Hemker HC; Rosing J
    Haemostasis; 1986; 16(3-4):216-26. PubMed ID: 3093336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and function of protein C.
    Stenflo J
    Semin Thromb Hemost; 1984 Apr; 10(2):109-21. PubMed ID: 6429858
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of a sulfated polysaccharide on antithrombin III.
    Czapek EE; Kwaan HC; Szczecinski M
    J Lab Clin Med; 1980 Jun; 95(6):783-90. PubMed ID: 6155418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new type of antithrombotic agent: action of antithrombin III - factor Xa complex.
    Bajwa SS
    Proc West Pharmacol Soc; 1981; 24():275-9. PubMed ID: 7255468
    [No Abstract]   [Full Text] [Related]  

  • 19. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prothrombin activation mechanism].
    Sakuragawa N
    Nihon Rinsho; 1974 May; 32(5):901-9. PubMed ID: 4603779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.